Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Clearside Biomedi (CLSD)

Clearside Biomedi (CLSD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,524
  • Shares Outstanding, K 74,731
  • Annual Sales, $ 8,230 K
  • Annual Income, $ -32,490 K
  • 60-Month Beta 2.34
  • Price/Sales 11.90
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CLSD with:

Options Overview Details

View History
  • Implied Volatility 365.88% ( +125.60%)
  • Historical Volatility 72.29%
  • IV Percentile 89%
  • IV Rank 39.65%
  • IV High 855.81% on 05/02/24
  • IV Low 44.07% on 09/11/24
  • Put/Call Vol Ratio 0.05
  • Today's Volume 783
  • Volume Avg (30-Day) 263
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 6,862
  • Open Int (30-Day) 3,454

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.14
  • Number of Estimates 3
  • High Estimate -0.13
  • Low Estimate -0.16
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9200 +43.40%
on 09/05/24
1.3800 -4.40%
on 09/17/24
+0.3093 (+30.62%)
since 08/16/24
3-Month
0.9200 +43.40%
on 09/05/24
1.3800 -4.40%
on 09/17/24
+0.1993 (+17.79%)
since 06/18/24
52-Week
0.6501 +102.94%
on 10/26/23
2.1200 -37.77%
on 03/12/24
+0.4703 (+55.39%)
since 09/18/23

Most Recent Stories

More News
Clearside Biomedical Announces Second Quarter 2022 Financial Results and Provides Corporate Update

- CLS-AX OASIS Phase 1/2a Trial Data from Cohorts 3 & 4 Expected in November 2022 - - Non-Dilutive Financing Agreement with HealthCare Royalty...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical Enters into Non-Dilutive Financing Agreement with HealthCare Royalty Partners for up to $65 Million

- Transaction Supports Progression of CLS-AX Clinical Program -...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical to Participate in Three Upcoming Investor Conferences in August 2022

ALPHARETTA, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical to Report Second Quarter 2022 Financial Results and Provide Corporate Update on Tuesday, August 9, 2022

ALPHARETTA, Ga., July 27, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical Completes Dosing in OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMD Patients

- CLS-AX Dosing Completed in Cohorts 3 and 4 - - Final OASIS Data Expected in Q4 2022 - ALPHARETTA, Ga., July 26, 2022 (GLOBE NEWSWIRE) -- Clearside...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical Suprachoroidal Delivery Technology to be Featured at Upcoming ASRS and OIS Medical Meetings

- Multiple Podium and Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® - ALPHARETTA, Ga., July 07, 2022 (GLOBE...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical Expands Leadership Team with Appointment of Susan Coultas, Ph.D., as Chief Clinical Officer

- Seasoned Life Science Executive Brings Expertise in Ophthalmic Clinical Development, Including Advancement of Multiple Late-Stage Programs to Product...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical to Participate in the JMP Securities Life Sciences Conference

ALPHARETTA, Ga., June 08, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical Announces First Quarter 2022 Financial Results and Provides Corporate Update

- First Approved Suprachoroidal Product, XIPERE®, Now Commercially Available in U.S. - - Cohort 4 Enrolling at 1.0 mg Dose in CLS-AX OASIS Wet AMD Phase...

CLSD : 1.3100 (+0.38%)
Clearside Biomedical Poster Presentation at ARVO 2022 Annual Meeting Demonstrates Versatility of Suprachoroidal Delivery Technology

- Multiple Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® - - Dr. Thomas Ciulla to Participate in a Panel...

CLSD : 1.3100 (+0.38%)

Business Summary

Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious...

See More

Key Turning Points

3rd Resistance Point 1.4767
2nd Resistance Point 1.4283
1st Resistance Point 1.3667
Last Price 1.3100
1st Support Level 1.2567
2nd Support Level 1.2083
3rd Support Level 1.1467

See More

52-Week High 2.1200
Fibonacci 61.8% 1.5585
Fibonacci 50% 1.3850
Last Price 1.3100
Fibonacci 38.2% 1.2116
52-Week Low 0.6501

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar